Gene therapy safely performed in NIDCR human salivary gland study

Bethesda, Md.—In a Phase I clinical study, National Institute of Dental and Craniofacial Research scientists safely transferred a gene to human salivary glands damaged by head and neck radiation for cancer therapy, potentially paving the way for dry mouth treatments.